486 related articles for article (PubMed ID: 27840336)
1. Ticagrelor Compared With Clopidogrel in Patients With Prior Lower Extremity Revascularization for Peripheral Artery Disease.
Jones WS; Baumgartner I; Hiatt WR; Heizer G; Conte MS; White CJ; Berger JS; Held P; Katona BG; Mahaffey KW; Norgren L; Blomster J; Millegård M; Reist C; Patel MR; Fowkes FG;
Circulation; 2017 Jan; 135(3):241-250. PubMed ID: 27840336
[TBL] [Abstract][Full Text] [Related]
2. Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease.
Hiatt WR; Fowkes FG; Heizer G; Berger JS; Baumgartner I; Held P; Katona BG; Mahaffey KW; Norgren L; Jones WS; Blomster J; Millegård M; Reist C; Patel MR;
N Engl J Med; 2017 Jan; 376(1):32-40. PubMed ID: 27959717
[TBL] [Abstract][Full Text] [Related]
3. Outcomes of Patients with Critical Limb Ischaemia in the EUCLID Trial.
Norgren L; Patel MR; Hiatt WR; Wojdyla DM; Fowkes FGR; Baumgartner I; Mahaffey KW; Berger JS; Jones WS; Katona BG; Held P; Blomster JI; Rockhold FW; Björck M;
Eur J Vasc Endovasc Surg; 2018 Jan; 55(1):109-117. PubMed ID: 29273390
[TBL] [Abstract][Full Text] [Related]
4. Acute Limb Ischemia in Peripheral Artery Disease.
Hess CN; Huang Z; Patel MR; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Held P; Jones WS; Katona B; Mahaffey KW; Norgren L; Rockhold FW; Hiatt WR
Circulation; 2019 Aug; 140(7):556-565. PubMed ID: 31238713
[TBL] [Abstract][Full Text] [Related]
5. Ticagrelor versus clopidogrel in patients with symptomatic peripheral artery disease and prior coronary artery disease: Insights from the EUCLID trial.
Berger JS; Abramson BL; Lopes RD; Heizer G; Rockhold FW; Baumgartner I; Fowkes FGR; Held P; Katona BG; Norgren L; Jones WS; Millegård M; Blomster J; Reist C; Hiatt WR; Patel MR; Mahaffey KW
Vasc Med; 2018 Dec; 23(6):523-530. PubMed ID: 29992857
[TBL] [Abstract][Full Text] [Related]
6. Design and rationale for the Effects of Ticagrelor and Clopidogrel in Patients with Peripheral Artery Disease (EUCLID) trial.
Berger JS; Katona BG; Jones WS; Patel MR; Norgren L; Baumgartner I; Blomster J; Mahaffey KW; Held P; Millegård M; Heizer G; Reist C; Fowkes FG; Hiatt WR
Am Heart J; 2016 May; 175():86-93. PubMed ID: 27179727
[TBL] [Abstract][Full Text] [Related]
7. Ticagrelor for Prevention of Ischemic Events After Myocardial Infarction in Patients With Peripheral Artery Disease.
Bonaca MP; Bhatt DL; Storey RF; Steg PG; Cohen M; Kuder J; Goodrich E; Nicolau JC; Parkhomenko A; López-Sendón J; Dellborg M; Dalby A; Špinar J; Aylward P; Corbalán R; Abola MTB; Jensen EC; Held P; Braunwald E; Sabatine MS
J Am Coll Cardiol; 2016 Jun; 67(23):2719-2728. PubMed ID: 27046162
[TBL] [Abstract][Full Text] [Related]
8. Reduction in first and recurrent cardiovascular events with ticagrelor compared with clopidogrel in the PLATO Study.
Kohli P; Wallentin L; Reyes E; Horrow J; Husted S; Angiolillo DJ; Ardissino D; Maurer G; Morais J; Nicolau JC; Oto A; Storey RF; James SK; Cannon CP
Circulation; 2013 Feb; 127(6):673-80. PubMed ID: 23277305
[TBL] [Abstract][Full Text] [Related]
9. Rivaroxaban and Aspirin in Peripheral Artery Disease Lower Extremity Revascularization: Impact of Concomitant Clopidogrel on Efficacy and Safety.
Hiatt WR; Bonaca MP; Patel MR; Nehler MR; Debus ES; Anand SS; Capell WH; Brackin T; Jaeger N; Hess CN; Pap AF; Berkowitz SD; Muehlhofer E; Haskell L; Brasil D; Madaric J; Sillesen H; Szalay D; Bauersachs R
Circulation; 2020 Dec; 142(23):2219-2230. PubMed ID: 33138628
[TBL] [Abstract][Full Text] [Related]
10. Total Cardiovascular and Limb Events and the Impact of Polyvascular Disease in Chronic Symptomatic Peripheral Artery Disease.
Szarek M; Hess C; Patel MR; Jones WS; Berger JS; Baumgartner I; Katona B; Mahaffey KW; Norgren L; Blomster J; Rockhold FW; Hsia J; Fowkes FGR; Bonaca MP
J Am Heart Assoc; 2022 Jun; 11(11):e025504. PubMed ID: 35621222
[TBL] [Abstract][Full Text] [Related]
11. Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial.
Olivier CB; Mulder H; Hiatt WR; Jones WS; Fowkes FGR; Rockhold FW; Berger JS; Baumgartner I; Held P; Katona BG; Norgren L; Blomster J; Patel MR; Mahaffey KW
JAMA Cardiol; 2019 Jan; 4(1):7-15. PubMed ID: 30540355
[TBL] [Abstract][Full Text] [Related]
12. Stroke in Patients With Peripheral Artery Disease.
Kolls BJ; Sapp S; Rockhold FW; Jordan JD; Dombrowski KE; Fowkes FGR; Mahaffey KW; Berger JS; Katona BG; Blomster JI; Norgren L; Abramson BL; Leiva-Pons JL; Prieto JC; Sokurenko G; Hiatt WR; Jones WS; Patel MR
Stroke; 2019 Jun; 50(6):1356-1363. PubMed ID: 31092165
[TBL] [Abstract][Full Text] [Related]
13. Assessment of Ticagrelor Versus Clopidogrel Treatment in Patients With ST-elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.
Tang X; Li R; Jing Q; Wang Q; Liu P; Zhang P; Liu Y
J Cardiovasc Pharmacol; 2016 Aug; 68(2):115-20. PubMed ID: 27010809
[TBL] [Abstract][Full Text] [Related]
14. Ticagrelor versus clopidogrel in patients with acute coronary syndromes undergoing coronary artery bypass surgery: results from the PLATO (Platelet Inhibition and Patient Outcomes) trial.
Held C; Asenblad N; Bassand JP; Becker RC; Cannon CP; Claeys MJ; Harrington RA; Horrow J; Husted S; James SK; Mahaffey KW; Nicolau JC; Scirica BM; Storey RF; Vintila M; Ycas J; Wallentin L
J Am Coll Cardiol; 2011 Feb; 57(6):672-84. PubMed ID: 21194870
[TBL] [Abstract][Full Text] [Related]
15. Safety and efficacy of ticagrelor and clopidogrel in primary percutaneous coronary intervention.
Velders MA; Abtan J; Angiolillo DJ; Ardissino D; Harrington RA; Hellkamp A; Himmelmann A; Husted S; Katus HA; Meier B; Schulte PJ; Storey RF; Wallentin L; Gabriel Steg P; James SK;
Heart; 2016 Apr; 102(8):617-25. PubMed ID: 26848185
[TBL] [Abstract][Full Text] [Related]
16. Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial.
Hopley CW; Kavanagh S; Patel MR; Ostrom C; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Jones WS; Katona BG; Mahaffey KW; Norgren L; Rockhold FW; Hiatt WR
Vasc Med; 2019 Oct; 24(5):422-430. PubMed ID: 31339474
[TBL] [Abstract][Full Text] [Related]
17. Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduits.
Govsyeyev N; Nehler M; Conte MS; Debus S; Chung J; Dorigo W; Gudz I; Krievins D; Mills J; Moll F; Norgren L; Piffaretti G; Powell R; Szalay D; Sillesen H; Wohlauer M; Szarek M; Bauersachs RM; Anand SS; Patel MR; Capell WH; Jaeger N; Hess CN; Muehlhofer E; Haskell LP; Berkowitz SD; Bonaca MP
J Vasc Surg; 2023 Apr; 77(4):1107-1118.e2. PubMed ID: 36470531
[TBL] [Abstract][Full Text] [Related]
18. Cardiovascular events in acute coronary syndrome patients with peripheral arterial disease treated with ticagrelor compared with clopidogrel: Data from the PLATO Trial.
Patel MR; Becker RC; Wojdyla DM; Emanuelsson H; Hiatt WR; Horrow J; Husted S; Mahaffey KW; Steg PG; Storey RF; Wallentin L; James SK
Eur J Prev Cardiol; 2015 Jun; 22(6):734-42. PubMed ID: 24830710
[TBL] [Abstract][Full Text] [Related]
19. Polyvascular Disease and Risk of Major Adverse Cardiovascular Events in Peripheral Artery Disease: A Secondary Analysis of the EUCLID Trial.
Gutierrez JA; Mulder H; Jones WS; Rockhold FW; Baumgartner I; Berger JS; Blomster JI; Fowkes FGR; Held P; Katona BG; Mahaffey KW; Norgren L; Hiatt WR; Patel MR
JAMA Netw Open; 2018 Nov; 1(7):e185239. PubMed ID: 30646395
[TBL] [Abstract][Full Text] [Related]
20. Ticagrelor vs. clopidogrel in patients with non-ST-elevation acute coronary syndrome with or without revascularization: results from the PLATO trial.
Lindholm D; Varenhorst C; Cannon CP; Harrington RA; Himmelmann A; Maya J; Husted S; Steg PG; Cornel JH; Storey RF; Stevens SR; Wallentin L; James SK
Eur Heart J; 2014 Aug; 35(31):2083-93. PubMed ID: 24727884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
